NPAT guidance 'revised' to $25m-$30m.
I didn't think they gave a NPAT outlook for FY24 previously just EBITDA inline with PY but with much higher financing costs?
Did I miss something in Aug?
Is that an upgrade or downgrade?
PE at $25m is approx 9.3 & 7.8 at $30m based on yesterday's close.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.60 |
Change
-0.005(0.31%) |
Mkt cap ! $310.4M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.64 | $1.58 | $244.2K | 150.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6000 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.63 | 5303 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| SVR (ASX) Chart |